Investor Relations

Press Release

November 13, 2024

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

More
November 6, 2024

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024

More
October 29, 2024

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024

More
August 28, 2024

Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference

More
August 7, 2024

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024

More
July 31, 2024

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024

More
June 4, 2024

Amphastar Announces Additional $50 Million Increase to its Share Buyback Program

More
June 3, 2024

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

More
May 22, 2024

Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol

More
May 9, 2024

Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference

More
Youtube